| Promoter stake change | +0.07% |
|---|
BSE filing, NSE: NEULANDLAB. Summary written from the filing by ALFA Finder's alert engine.
Neuland Laboratories Ltd: key numbers
- Share price
- ₹19,970.00
- Market cap
- ₹25,621 Cr
- Revenue (annual)
- ₹2,023 Cr
- Net profit (annual)
- ₹364.0 Cr
- P/E (TTM)
- 51.5×Sector 46.1×
- Promoter holding
- 32.26%-0.36% QoQ
- FII holding
- 21.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neuland Laboratories Ltd
All →Neuland Laboratories Board Meeting Date
Neuland Laboratories will hold a board meeting on November 3, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Neuland Laboratories Business Update
Neuland Laboratories' Unit 3 manufacturing facility received an Establishment Inspection Report from the US FDA. The agency has officially closed the inspection.
Neuland Laboratories Other Announcement
Neuland Laboratories Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI Regulation 31.
Neuland Laboratories Production Started
Neuland commissioned its first commercial peptide manufacturing module with 7,000L reactor capacity. Module two expansion is underway to meet rising customer demand for peptide APIs.
- peptide manufacturing reactor capacity
- 7000 L
Neuland Laboratories Capacity Expansion: ₹126 Cr Investment
Neuland Laboratories' board approved ₹126 Crore capex to acquire 134 acres of land in Andhra Pradesh for future expansion. The company holds ROFR on additional land.
- Value
- ₹126.0 Cr
- land acquisition
- 134.0 acres
Neuland Laboratories Credit Rating
Neuland Laboratories announced that CRISIL Ratings has reaffirmed its long-term credit rating at CRISIL A+/Positive and its short-term rating at CRISIL A1.
Other promoter selling (off-market) announcements
All →Keltech Energies Promoter Selling (Off-Market)
Keltech's promoter Chowgule and Company received a letter of intent to transfer 4,09,940 shares to Vijay Chowgule. The off-market, no-cash transfer keeps promoter holding unchanged.
Chowgule Steamships Promoter Selling (Off-Market)
Chowgule and Company Private Limited, a promoter group entity, proposed transferring 1,74,50,333 shares to family members under a family settlement. The transfer is off-market, without cash consideration.
Hemo Organic Promoter Selling (Off-Market): ₹0.09 Cr
Hemo Organic promoter Dineshbhai Shanabhai Patel sold 155,986 shares off-market for ₹0.09 Cr, cutting stake from 2.40% to 0.13%.
- Value
- ₹0.09 Cr
Hemo Organic Promoter Selling (Off-Market)
Promoter Dineshbhai Patel disposed 1,55,986 Hemo Organic shares off-market on 24 Oct 2026, cutting his stake to 0.13%. No transaction value was disclosed in the filing.
- Promoter stake change
- -2.27%
Valor Estate Promoter Selling (Off-Market)
Promoter Shravan Bali transferred 10.01 lakh shares (0.18% stake) to Shruti Ahuja via an off-market gift, reducing his holding to nil.
- Promoter stake change
- -0.18%
The Bombay Burmah Trading Corporation Promoter Selling (Off-Market)
Nusli N. Wadia sold 22,45,000 Bombay Burmah shares to an existing promoter via inter-se block deal. His stake fell from 5.06% to 1.84%.